Bard Medical Bardex Lubricath Coude Catheter 5cc
Item #: BA0168L14
The Bard Medical Bardex Lubricath Coude Catheter 5cc provides for smoother insertion and enhanced patient comfort given the hydrogel coating's unique ability to absorb fluid, thus creating a hydrophilic "cushion" between the catheter surface and the urethra.
The Bard Medical Bardex Lubricath Coude Catheter 5cc provides for smoother insertion and enhanced patient comfort given the hydrogel coating's unique ability to absorb fluid, thus creating a hydrophilic "cushion" between the catheter surface and the urethra. Available in a medium length, olive Coudé tip design that facilitates negotiation of the prostatic urethra along with a single drainage eye.
- Bard 2-Way Bardex® Lubricath® Speciality 5 cc Foley Catheters are single-use and sterile.
- 5 cc balloon for postoperative hemostasis.
- Allows for atraumatic insertion thus providing enhanced patient comfort.
- Hydrogel coating maintains its integrity throughout the course of use, resulting in less trauma upon removal.
- Used to negotiate the male urethra, particularly when a structure or BPH is present.
- Coudé tip is useful in negotiating the neck of the bladder in female patients, allowing easier insertion and reduced irritation.
- Balloon is round and short to provide excellent seating in the bladder to minimize leakage and irritation to the trigone.
- Slightly larger bulb to assist in negotiation of restrictions.
- Features Bacti-Guard® silver alloy coating and Bard® hydrogel, proven to reduce the incidence of catheter-associated urinary tract infections (CAUTIs).
|Bard Medical Bardex Lubricath Coude Catheter 5cc
||570168L14 - 14 FR
||570168L16 - 16 FR
||570168L18 - 18 FR
||570168L20 - 20 FR
||570168L22 - 22 FR
||570168L24 - 24 FR
Physician Order: This item requires a physician order, please provide your physician's information during checkout. At this time we are unable to ship this product to North Dakota.
This product does not have any optional accessories.
This product does not have any reviews.